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ABSTRACT 
 
Cataract is an opacification of the eye lens, constituting the major cause of blindness 
globally. Oxidative stress is a key factor in the formation of cataract and female gender 
is a known risk factor for age-related cataract. The aim of this thesis was to investigate 
the role of estrogen and the antioxidant enzyme superoxide dismutase (SOD) in 
cataractogenesis. 
Human lens epithelial cells (HLECs) obtained during cataract surgery at the 
Department of Ophthalmology at Sahlgrenska university hospital in Mölndal (SU/M) 
were used to study the effects of the major estrogen, 17β-estradiol (E2), on 
proliferation, cell viability, intracellular redox status, SOD and estrogen receptors (ERs). 
H2O2-induced oxidative stress was used to study the antioxidative properties of E2 in 
HLECs. Two genetic association studies were performed to investigate if genetic 
variations in estrogen-related and in SOD genes were associated with increased risk of 
cataract in an Estonian population, consisting of 492 patients with age-related cataract 
and 185 controls. Patients and controls were also recruited from the Eye Clinic at 
SU/M for a study on possible correlations between E2 levels and SOD activity. 
The effects of E2 at pharmacological concentrations in HLECs were; increased 
apoptosis and cell death, reduced cell viability and proliferation as well as increased 
intracellular levels of reactive oxygen species (ROS). At lower (physiologic) 
concentrations, increased proliferation, reduced cell death, stabilization of mitochondrial 
membrane potential and protection against oxidative stress by reduction of ROS were 
observed. At these concentrations total SOD activity was increased and protein 
expression levels of ERs were altered. However, no change in neither gene nor protein 
expression levels of SODs was seen. A linear correlation between increasing age and 
declining E2 serum levels was evident in cataract patients and controls. Men exhibited 
higher E2 levels compared to postmenopausal women. However, no correlation 
between serum levels of E2 and SOD activity was found in our study subjects. The 
genetic association studies showed that genetic variations in SOD and estrogen-related 
genes were not associated with increased risk of cataract. 
In conclusion, no correlation between SOD activity and E2 serum levels in 
cataract patients and controls was found and genetic variations in SOD or estrogen-
related genes showed no association with increased risk of cataract in our subjects. The 
observed increase in SOD activity after exposure to E2 and reduction of ROS after 
preincubation with E2  in  oxidatively stressed cells, support a  role  for E2 in the 
protection against oxidative stress in HLECs. The antioxidative effect of E2 in lens 
epithelial cells appears to be induced by non-genomic mechanisms. 
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ABBREVIATIONS 
 
AP-1 activator protein 1 
ATP adenosinetriphosphate 
BCA bicinchoninic acid 
BSA bovine serum albumin 
cDNA complementary deoxyribonucleic acid 
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CO2 carbon dioxide 
COMT catechol-O-methyltransferase 
Ct cycle threshold 
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DCFH-DA 2’,7’-dichlorofluorescein diacetate 
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DNA deoxyribonucleic acid 
DTT dithiothreitol 
E1 estrone 
E2 estradiol (17β-estradiol) 
E3 estriol 
EPHA2 ephrin receptor A2 
ER estrogen receptor 
ERE estrogen response element 
ERK extracellular signal-regulated kinase 
FBS fetal bovine serum 
GPx  glutathione peroxidase 
GR glutathione reductase 
GSH reduced glutathione 
GSSG oxidized glutathione 
GST glutathione S-transferase 
H2O2 hydrogen peroxide 
HET hydroethidine, dihydroethidium 
HLE-B3 human lens epithelial B3 (transformed) cells 
HLEC human lens epithelial cells 
HRP horseradish peroxidase 
HRT hormone replacement therapy 
HSP heat shock protein 
HWE Hardy-Weinberg equilibrium 
JC-1 5,5′,6,6’-tetrachloro-1,1’,3,3′- tetraethylbenzimidazolylcarbocyanine iodide 
LD linkage disequilibrium 
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LDS lithium dodecyl sulfate 
MAPK mitogen-activated protein kinase 
MCB monochlorobimane 
MEM minimum essential medium 
MTT 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide 
NADPH nicotinamide adenine dinucleotide phosphate 
NO! nitric oxide 
NO− nitric oxide anion 
NOS nitric oxide synthase 
O2 oxygen  
O2!− superoxide 
1O2 singlet oxygen 
ONOO− peroxynitrite 
!OH hydroxyl radical 
OH− hydroxide anion 
OR odds ratio 
PBS phosphate buffered saline 
PCO posterior capsular opacification 
PCR polymerase chain reaction 
PI propidium iodide 
PMSF phenylmethylsulfonyl fluoride 
Prx peroxiredoxin 
PSC posterior subcapsular cataract 
qPCR quantitative polymerase chain reaction 
RFU relative fluorescence unit 
RNA ribonucleic acid 
ROS reactive oxygen species 
RT-PCR reverse transcription polymerase chain reaction 
SDS  sodium dodecyl sulfate 
SHBG sex hormone-binding globulin 
SNP single nucleotide polymorphism 
SOD superoxide dismutase 
TGFβ transforming growth factor β 
Vmax maximum velocity 
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INTRODUCTION 
 
The human eye lens 
The lens is an important component of the optical system of the eye, together 
with the cornea responsible for refraction of light. For light to be transmitted 
and focused on the retina, the most important feature of the lens is 
transparency. Transparency is due to a highly organized system of lens cells, so 
called lens fibers. The shape, arrangement, internal structure and biochemistry 
of these cells make the lens unique, resulting in a transparent and avascular 
tissue, which receives its nourishment from the aqueous and  vitreous humors. 
The lens is positioned in front of the vitreous body, behind the iris and is 
enclosed in a capsule (Figure 1).1, 2
The lens capsule is an elastic thick basement membrane, produced by 
the lens epithelium and it is attached to the zonular fibers at the lens equator. 
The zonules mediate movements from the ciliary muscle to the lens through the 
capsule. This is called accommodation and when the shape of the lens changes, 
it results in altered refractive power. Oxygen, glucose, amino acids, fatty acids 
and other nutrients pass through the capsule to the lens and waste products as 
lactate and CO2 are transported out.1, 3 
 
 
Figure 1. The human eye (left) and schematic drawing of the human lens (right). 
 
The lens epithelium is a single layer of epithelial cells on the anterior surface of 
the lens, inside the capsule. As the cells divide they migrate to the lens equator, 
where differentiation takes place. The cells are then elongated and packed 
towards the center, the nucleus, of the lens (Figure 1). When the cells 
differentiate into thin fiber cells, they are tightly packed with minimal 
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extracellular space and lose all organelles as well as nuclei, processes that 
contribute to the lens transparency.3, 4  
The lens fibers mostly contain water-soluble proteins, α-, β- and γ-
crystallins, residues from the epithelial cells where they are produced. The most 
metabolically active part of the lens is the lens epithelium located on the anterior 
and pre-equatorial region of the lens. As the cells are packed towards the 
nucleus they lose their organelles, however the cells between the nucleus and 
equator, in the superficial lens cortex, can still be nucleated and metabolically 
active.2, 3 Cortical lens fibers, as well as fibers in the nucleus, have been reported 
to exhibit some enzyme activity.5, 6 The lens epithelium is a major site of 
detoxification and defense against oxidative stress and enzyme activity of several 
antioxidant defense systems have been detected.7 
 
Aging of the lens 
The primary lens fibers are formed before birth, during lens formation and are 
part of the lens throughout life in the innermost part of the lens nucleus. The 
lens epithelial cells continue to divide throughout life and more lens fibers are 
produced that are then tightly packed towards the nucleus, consequently leading 
to thickening of the lens during aging. Also, the curvature of the anterior 
surface of the lens changes so that the lens becomes more convex and the 
insertion point of the zonules is altered due to the age-related changes to the 
lens and capsule. Together with other age-related changes such as reduced 
elastic properties of the lens and a weakening of the ciliary muscle, a gradual 
decrease in accommodation is experienced from the age of forty, resulting in 
diminished ability to focus on near objects, a condition called presbyopia8, 9 
Age-related changes of the lens proteins include post-translational 
modifications, conformational changes and loss of chaperone function. The 
ubiquitin-proteasome pathway is involved in degradation and removal of 
oxidized proteins and the activity of the ubiquitin conjugation activity decreases 
in the aging lens – contributing to accumulation of damaged and aggregated 
proteins resulting in loss of transparency, increased coloration and light 
scattering with age.9 
During life we are constantly exposed to external physical and chemical 
agents and this is also the case for the lens where the lens epithelium is a major 
site of detoxification. However, the enzyme activity levels of several of the 
defense systems are reduced in the lens epithelium during aging. The nucleus, 
where the oldest lens fibers are found, has been demonstrated to have least 
protection and is particularly at risk of damage.9, 10  
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Cataract 
Cataract is defined as opacification (clouding) of the normally transparent lens, 
which causes impaired visual function due to light-scatter. Cataractogenesis is 
the process of cataract formation and it is considered the leading cause of visual 
impairment and the most common cause of blindness in the world. The most 
recent report on visual impairment globally, describes cataract as being 
responsible for 51% of all blind patients and 33% of all patients with visual 
impairment, the second major cause after uncorrected refractive errors.11  
As mentioned previously, increased aggregation and insolubility of 
proteins, light scattering and loss of transparency are features of the aging 
human lens and can be seen as precursors of cataract.9 Age-related cataract (also 
called senile cataract) is a multifactorial disease and besides the major risk factor 
– aging – there are several other factors that contribute to development of lens 
opacities such as; gender, smoking, genetic predisposition, diabetes, ultraviolet 
(UVB) and ionizing radiation. Drugs or mechanical trauma can also induce 
cataract. Ethnicity, obesity, hypertension, socioeconomic status, estrogen 
exposure, antioxidants and alcohol are also factors that have been linked to the 
disease.12-17 
The main types of age-related cataract are divided into nuclear, cortical 
and posterior subcapsular cataract (PSC) or a mixture of these types, depending 
on where the lens opacities are located. Nuclear cataracts occur in the lens 
nucleus, the central part of the lens, composed of fiber cells that are present at 
birth.  Cortical cataract occurs in the fibers in the outer part of the lens, the 
cortex, most often starting in the equatorial parts of the lens, while posterior 
subcapsular opacities are located in the central part of the posterior superficial 
lens fibers. PSC is considered as being formed from fiber cells that fail to 
differentiate properly, resulting in migration and accumulation at the posterior 
pole of the lens. However, this type of cataract is the least common. The 
prevalence of the different types of cataract differs between ethnicity and 
different regions of the world, but nuclear cataract is reported as being the most 
common type overall.18  
 
Nuclear cataract  
Nuclear cataract is characterized by oxidation, loss of reduced glutathione 
(GSH), increased coloration and modifications of nuclear proteins such as 
insolubilization and cross-linking. The lens fibers are relatively intact and loss of 
transparency is instead caused by protein aggregates that cause light scatter and 
the coloration i.e. yellow/brown pigmentation which absorbs light. The reduced 
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transparency results in more impaired distant vision than near vision. A typical 
finding in nuclear cataract is also the loss of GSH in the nuclear region, which is 
due to oxidation – a key feature in the formation of nuclear cataract.19, 20  
Smoking is a consistent risk factor for nuclear cataracts and the risk for 
developing nuclear opacities increases with the amount and duration of 
smoking.14, 21, 22 Nuclear opacities have also been associated with white race, 
lower education and family history of cataract.15 
 
Cortical cataract 
As opposed to nuclear cataract, cortical cataract shows several major 
histological changes of the lens fiber arrangement. The changes involve 
disruption of fiber cell membranes resulting in swelling due to leakage of 
cytoplasmic content of damaged fiber cells. The effect on vision varies and 
depends on the location of the opacities.2 
Most epidemiologic studies indicate that female gender is most strongly 
associated with cortical cataract and to some, but lesser extent, with nuclear 
cataract.13, 16, 23 Also, non-white race, diabetes, heredity and UVB exposure have 
been associated with increased risk of cortical cataract.17, 24-26 The Salisbury Eye 
Evaluation project demonstrated that exposure to UVB radiation from sunlight 
increases the risk of developing cortical lens opacities by 10%.27 Several 
experimental studies have confirmed the increased risk of UVB exposure with 
cataract formation.17, 28 
 
Posterior subcapsular cataract 
Posterior subcapsular opacities are formed from fiber cells that fail to 
differentiate properly. Instead of cells elongating, they migrate and accumulate 
at the posterior surface of the lens. As in cortical cataract, disruption and 
swelling of lens fibers occur. Near vision is often more reduced than distant 
vision.2 
Long-term use of steroids such as glucocorticoids is a major risk factor 
of developing PSC and this has been confirmed in both epidemiologic and 
experimental studies.29, 30 Diabetes has also been associated with increased risk 
for PSC, as well as male gender and ionizing radiation.31, 32 
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Oxidative stress 
Aerobic metabolism generates reactive oxygen species (ROS), a term that is 
often used to describe molecules or free radicals that can cause oxidative stress. 
Disturbance of the balance between ROS generated by normal metabolism or 
exogenous sources, and the antioxidant defense leads to oxidative stress, which 
can cause oxidative damage to biomolecules such as protein, lipids, 
carbohydrates and DNA.33, 34 However, oxidative stress does not always lead to 
oxidative damage depending on severity of the oxidative stress and cell type. 
Cells can respond to mild oxidative stress by proliferation or adapting and 
upregulating defense systems, which results in cells becoming more resistant to 
higher levels of oxidative stress. But if defense systems cannot handle the 
increased production of ROS, then oxidative stress can lead to oxidative damage 
to biomolecules, senescence and even cell death.33  
Oxidative stress plays a key role in cataractogenesis, which has been 
shown in experimental as well as in epidemiological studies. Elevated hydrogen 
peroxide levels have been demonstrated in lenses and aqueous humor from 
cataract patients.35 With increasing age, the lens as well as other tissues is more 
susceptible to oxidative stress and less able to repair oxidative damage. 
Increased oxidation of reduced glutathione (GSH) to oxidized glutathione 
(GSSG) in the nuclear region of the lens as well as oxidation resulting in 
extensive modification of nuclear proteins have been demonstrated in the 
lens.19, 20, 36 Several of the risk factors for cataract identified in epidemiological 
studies - smoking, radiation and diabetes - results in oxidative stress. Smoking is 
a well-known risk factor and has been associated with nuclear cataract in several 
studies.14, 21, 22 Other source of oxidative damage is radiation and especially UV. 
As we age the eyes are more susceptible to UV damage due to decrease of UV 
filters in our lenses.37 The incidence of cataract is higher in diabetics as 
compared to non-diabetics and a combination of glycemic and oxidative stress 
is implied in the pathogenesis even though the exact mechanisms are not fully 
elucidated.38 
As oxidative mechanisms are of importance in cataract formation, 
several large clinical trials have investigated if dietary antioxidants could have 
beneficial effects on cataract prevention or not, but the results have been 
inconsistent. A randomized clinical trial that included 4757 participants, The 
Age-Related Eye Disease Study (AREDS), found no effect on cataract incidence 
after supplementation with vitamin C, E and β-carotene.39 Neither in the 
Australian, The Vitamin E, Cataract and Age-related macular degeneration Trial 
(VECAT), no effects of high dose vitamin E on cataract incidence or 
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progression were found.40 However, small protective effects of antioxidant 
mixture of vitamin C, E and β-carotene were found in a smaller trial, The Roche 
European-American Anticataract Trial (REACT).41 
 
Reactive oxygen species & Aging 
In 1956 Denham Harman introduced “the free radical theory of aging” which 
suggested that free radicals cause accumulative and irreversible damage to 
macromolecules, loss of cellular function resulting in cell death – impacting 
both health and lifespan.42 The importance of ROS in the aging process has 
been supported by a number of studies. Maximal lifespan of species is inversely 
correlated with the ROS-generating potential in many tissues but positively 
associated with the antioxidant capacity and it can also be prolonged by 
overexpression of antioxidant enzymes.43, 44 Mitochondria are a major source of 
ROS production and have been implied as a target of oxidative damage during 
aging.45 Additionally, more ROS and less ATP is produced in mitochondria 
during aging in mammalian tissue.46 Interestingly, the age-related dysfunction of 
mitochondria exhibits gender-related differences, something that has been 
suggested to contribute to the difference in lifespan between male and females.  
Borras et al. have demonstrated that mitochondria from female rats generate 
half the amount of peroxides as compared to those from male rats, and this was 
not evident in ovariectomized rats. They also demonstrated that mitochondrial 
DNA from males exhibits 4 times higher levels of oxidative damage and that 
mitochondria from female rats have higher expression of the antioxidant 
enzymes.47 
 
Reactive oxygen species in the lens 
The lens metabolism is predominantly anaerobic and aerobic metabolism takes 
place solely in the lens epithelium. Oxygen can enter the lens via diffusion from 
the surrounding aqueous and vitreous humor. In the lens epithelium and 
superficial cortical lens fibers, mitochondrial respiration accounts for 
approximately 90% of the oxygen consumed by the lens, however other non-
mitochondrial consumers of oxygen have also been demonstrated.48 During 
mitochondrial respiration, ROS are produced via the electron transport chain 
where inefficient electron coupling leads to the formation of superoxide. ROS 
are also produced during cellular response to inflammation and viral infections 
and besides these endogenous sources of ROS, the lens is also exposed to 
exogenous sources of oxidative stress such as UVB exposure, ionizing radiation, 
cigarette smoke and drugs.12, 14, 17, 32 ROS generated from the iris, ciliary body or 
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corneal endothelial cells can be accumulated in the anterior chamber, as 
hydrogen peroxide for example, and may then diffuse into the lens. In addition, 
ROS generated from the retina can be transported through the vitreous body 
and diffuse posteriorly into the lens. Hence, the anatomical location of the lens 
makes it relatively accessible and susceptible to ROS.49 
ROS is a collective term that includes not only free radicals (with 
unpaired electrons) but also some non-radical derivates from oxygen. They are 
by-products or produced in different redox reactions i.e. when atoms undergo 
reduction (gain of electrons) or oxidation (loss of electrons).33 Here are some of 
the most important ROS described in the lens: 
 
Singlet oxygen (1O2) is more oxidizing than ground-state oxygen but still not a 
free radical since it does not have unpaired electrons. It is generated through 
absorption of photochemical energy in photosensitized reactions, such as 
radiation.33 
 
Superoxide (O2!−) is a radical formed when oxygen is reduced, i.e. one electron 
is added to the ground-state oxygen, and it can be generated by NADPH 
oxidases, xanthine oxidase or through autoxidation of molecules such as GSH. 
The major source of O2!− is the mitochondria, during energy production. O2!− is 
also a by-product of inflammatory response and generated in photosensitized 
reactions. Even though it is a radical it is not highly reactive but at high levels it 
can still cause extensive damage to proteins (containing iron-sulfur clusters) and 
most importantly it forms reactive intermediates such as hydroxyl radicals and 
peroxynitrite. The radical will not readily cross cell membranes and in aqueous 
solution one O2!− is oxidized to O2 and another is reduced to hydrogen peroxide 
in a dismutation reaction (Figure 2).33 
 
Hydrogen peroxide (H2O2) moves through cell membranes and is generated 
by several enzymes. It is poorly reactive and a weak oxidizing or reducing agent. 
However, it can still be cytotoxic, capable of inactivating enzymes, increasing 
O2!− production by activating NADPH oxidases, as well as forming damaging 
species such as hydroxyl radicals (Figure 2). It can be generated through the 
dismutation of O2!−, by xanthine oxidase and several other oxidases.33 H2O2 is 
often used to induce oxidative stress in lens epithelial cells in an experimental 
setting.  
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Hydroxyl radical (!OH) is a highly reactive free radical that can be generated 
by reaction with metal ions with H2O2, from ozone or peroxynitrite or when 
hypochlorous acid reacts with O2!?. It can also be generated by other sources 
such as ultrasound, UV and ionizing radiation. !OH has high positive redox 
potential and can react with many different molecules, causing damage to amino 
acids, carbohydrates, phospholipids and DNA bases. H2O2 can accelerate !OH 
production with transitional metals such as iron (Fe2+) in the Haber-Weiss 
Fenton reactions (Figure 2).33 
Nitric oxide (NO!), also called nitrogen monoxide, is a gaseous free radical that 
can react with O2!? to form peroxynitrite, a reaction that is competitive with the 
dismutation reaction. NO! is synthesized by the nitric oxide synthase (NOS) 
enzymes (Figure 2).33 
 
Peroxynitrite (ONOO?) is a non-radical formed from NO- and O2 or by the 
more common combination of NO! and O2!? (Figure 2). It is fairly unreactive 
although it can oxidize thiols and methionine among other molecules. It can 
also cause damage through oxidation of lipids, nitration of amino acids and 
DNA bases, resulting in DNA strand breaks and inactivation of enzymes.33 
 
Figure 2. Major reactive oxygen species (ROS) and antioxidant enzymes in the lens. 
O2: oxygen; O2!-: superoxide; NO!-: nitric oxide; NOS: nitric oxide synthase; ONOO?: peroxynitrite; SOD: superoxide 
dismutase; H+: hydrogen; H2O2: hydrogen peroxide; Fe2+/Fe3+ iron; !OH hydroxyl radical; OH-hydroxide anion; Prxs: 
peroxiredoxins; GPx: glutathione peroxidase; GSH: reduced glutathione; GSSG: oxidized glutathione. 
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Defense systems in the lens 
Imbalance between produced ROS and the antioxidant defense in cells leads to 
oxidative stress. This can result from reduced antioxidant defense and/or 
increased production of ROS.33 Here are some of the antioxidant enzymes 
described in the lens: 
 
Superoxide dismutase is involved in the dismutation of O2!− into O2 and 
H2O2, described in detail later. 
 
Catalase is normally found in the peroxisomes where it detoxifies H2O2 into 
water. Even though it has been demonstrated that increasing catalase expression 
in human lens epithelial cells (HLECs) protects against H2O2-induced oxidative 
stress,50 lenses from mice lacking catalase did not show increased susceptibility 
to oxidative stress.51 Hence, suggesting that catalase is not the most important 
enzyme involved in H2O2 scavenging. 
 
Peroxiredoxins (Prxs), there are six different Prxs found in different organelles 
of mammalian cells; peroxisomes, mitochondria and endoplasmic reticulum, as 
well as in the cytosol. They are peroxide scavengers that have redox active 
cysteines and use the thioredoxin system as electron donor to scavenge H2O2 
and ONOO −  among other hydroperoxides.52 In HLECs and fiber cells, 
significant mRNA and protein levels of one of the Prxs found in mitochondria 
(Prx 3) have been detected and this Prx was also induced by H2O2 in HLECs, 
suggesting that Prx 3 has an important role in detoxifying H2O2 in the lens.53 
 
Glutathione peroxidase (GPx or GSHPx) reduces H2O2 into water through 
oxidation of GSH, which donates hydrogen and forms GSSG.54 In a study, 
lenses from transgenic mice with elevated GPx activity was compared with 
lenses from GPx knockout mice. The lenses were exposed to H2O2 and the 
lenses from mice with elevated GPx levels showed significantly less cytotoxic 
effects and DNA strand breaks, when evaluating morphological changes in the 
epithelium and superficial cortex, compared to knockout lenses, thus suggesting 
that increased GPx activity protects the lens against H2O2-induced damage.55 
Furthermore, it has also been demonstrated that GPx activity is reduced in 
cataractous lenses, suggesting that increased oxidative stress is involved in 
cataract formation.56 
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Glutathione 
There are several other defense systems involved in protecting the lens from 
oxidative damage besides antioxidant enzymes, such as ROS scavengers. Those 
are non-enzymatic molecules that bind and detoxify ROS. One of the major 
ROS scavengers in the lens is reduced glutathione (GSH), unusually abundant in 
the lens compared to other tissues. GSH is predominately found in its reduced 
form in the lens epithelium during normal metabolism and also found in lens 
fibers in high levels. The lens epithelium contains an active glutathione redox 
cycle, which reduces the oxidized form of glutathione, GSSG, back to GSH in a 
reaction catalyzed by glutathione reductase (GR) using NADPH as reducing 
agent.20, 57 As mentioned previously, decreased levels of reduced GSH is seen in 
aging and cataractous lenses, as well as decreased GR activity levels. As reduced 
GSH is decreased, the oxidized form GSSG increases.36, 58 The function of GSH 
in the lens is to preserve protein thiol groups in their reduced form which 
maintains normal protein function. When the levels of GSH are decreased and 
GSSG is formed in the lens, this is believed to increase the rate of 
posttranslational modifications of crystallins and damage key proteins 
containing –SH groups and proteins associated with membrane permeability.59, 
60 Ultimatley, these oxidatively induced protein modifications lead to increased 
cross-linking and formation of light scattering protein aggregates. 
Other powerful ROS scavengers are vitamin C (ascorbate), vitamin E 
and carotenoids such as lutein and zeaxanthin. There are also other defense 
systems in the lens; free metal detoxifiers, protein repair systems, reducing 
systems and chaperone proteins.61 
 
Superoxide dismutase 
Superoxide dismutase (SOD) is involved in the detoxification of superoxide 
(O2!−) by dismutation and is one of the major antioxidant enzymes. Dismutation 
is a reaction in which the same species is both oxidized and reduced, in this case 
superoxide, when one O2!− is oxidized to O2 and another is reduced to H2O2.33 
Since superoxide not readily crosses cell membranes there are three SOD 
isoenzymes in mammalians; SOD-1, SOD-2 and SOD-3. They are encoded by 
three separate genes and confined to separate compartments of the cell. These 
metalloenzymes use copper-zinc or manganese to scavenge superoxide.62  
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SOD-1 
The first SOD isoenzyme to be discovered was SOD-1, also called CuZn-SOD 
or erythrocuprein. This dimeric protein binds one copper and one zinc atom to 
each subunit. The copper atom is important for the catalytic activity and 
although zinc is not involved in the enzymatic activity it is important for 
maintaining the structure. The primary location of SOD-1 is in the cytosol but it 
is also found in the nucleus.63 This enzyme is encoded by SOD1 located on 
chromosome 21. Several mutations in this gene have been described in 
individuals with familial amyotrophic lateral sclerosis.64, 65 In Down syndrome, 
triplication of chromosome 21 include the SOD1 gene, resulting in elevated 
levels of SOD-1 activity. Paradoxically, this SOD-1 overexpression does not 
increase the antioxidant capacity of the cells, but instead appears to generate 
more oxidative stress.66, 67  
 
SOD-2  
The second isoenzyme discovered was the manganese-containing enzyme, 
SOD-2, also called Mn-SOD. This tetrameric protein contains Mn in the active 
site and it is primarily located in the mitochondrial matrix. It is highly important 
in detoxifying O2!− produced during mitochondrial respiration.68 Mice deficient 
in SOD-2 exhibit high neonatal lethality, whereas mice lacking SOD-1 or SOD-
3 have less pronounced effects on survival.69-71 SOD-2 is encoded by SOD2 on 
chromosome 6.72, 73 Genetic polymorphisms in the gene have been associated 
with increased risk of diseases such as Alzheimer’s disease, Parkinson’s disease, 
prostate and breast cancer,74-79 as well as aging and longevity.80 
 
SOD-3 
The last discovered isoenzyme was SOD-3, also called CuZn-SOD, due to the 
same metals in the active site as SOD-1. Unlike SOD-1 it is a tetrameric protein 
with higher molecular weight. It has a heparin-binding domain and is primarily 
found in the extracellular space (therefore also called EC-SOD), but it can also 
bind to cell surfaces through heparin sulfate proteoglycans.81 In contrast to 
SOD-1 and SOD-2, the expression of SOD-3 appears restricted to only a few 
cell types in several tissues. SOD-3 can be proteolytically modified resulting in 
different forms of SOD-3 with altered affinity for heparin.82 SOD-3 is encoded 
by SOD3 located on chromosome 4.83 A mutation in this gene have been shown 
to reduce heparin affinity resulting in a 10-fold increase of SOD-3 in human 
plasma.84 
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Superoxide dismutase in cataractogenesis 
Given the composition of the eye lens, which is largely built up of tightly 
stacked lens fibers containing cytoplasm devoid of organelles, it is not surprising 
that SOD-1 is the predominant isoenzyme. The amount of SOD-2, which is 
likely confined to the lens epithelium and the superficial lens fibers, is relatively 
low in the human eye lens and the content of SOD-3 is negligible as the lens 
comprise very little extracellular space. However, SOD-3 is produced and 
secreted by lens epithelial cells and can be detected in the cell culture medium 
when the cells are cultured.85 Although SOD activity is relatively low in the 
human lens as compared to other tissues, the role of SOD in the lens and in the 
pathogenesis of cataract may still be of importance. 
Protective effects of SOD-1 against H2O2-induced oxidative damage 
have been demonstrated in whole rat lenses when SOD-1 protein and activity 
levels were overexpressed.86 Protective effects were also seen when SOD-2 
levels were upregulated in a transformed human lens epithelial cell line, as cells 
were more resistant to oxidative damage and showed greater cell viability.87 
Also, lenses from Sod1 knockout mice developed age-related lens opacities 
earlier than wild-type mice, suggesting that SOD participates in the protection 
against age-related cataract.88 Studies have also demonstrated reduced SOD 
activity in cataractous lenses as compared to clear lenses from humans.56, 89 In 
addition, this decline in SOD activity has been demonstrated in aging lenses.90 
Rajkumar et al. have also demonstrated that SOD activity declines gradually with 
age; the highest levels of SOD were found in samples from patients 50 years of 
age or younger. They also showed varying levels of total SOD activity in 
patients with cataract depending on cataract subtype. SOD activity was highest 
in lens capsules samples from cortical cataract patients.91 There have been 
reports of increased SOD activity in erythrocytes in cataract patients compared 
to controls and the POLA study group also showed an increased incidence of 
cortical cataract in patients with high SOD activity in erythrocytes.92-94 However, 
conflicting data on SOD activity levels also exist and there are studies showing 
decreased SOD activity levels in erythrocytes, sera and lenses from cataract 
patients compared to controls.95-97 
Studies with synthetic SOD mimics, Tempol and the reduced form 
Tempol-H, have showed protective effects against lens opacifications in organ 
culture and animal models. The synthetic compounds inhibited opacification of 
H2O2-induced damage in lenses in culture as well as protected against x-ray 
induced lens damage in rabbit.98, 99  
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Cataract & Gender 
Female gender is consistent as a risk factor for cataract in several epidemiologic 
studies.13, 16, 100-102 As mentioned, most epidemiologic studies indicate that 
female gender is most strongly associated with cortical cataract and to some, but 
lesser extent, with nuclear cataract.13, 16, 23 Several lifestyle-related factors 
generally associated with cataract, such as UVB exposure and smoking habits, 
cannot explain the gender difference, since UVB exposure is higher and 
smoking more prevalent in men. It has also been suggested that there are 
gender-related differences in self-assessment of visual function and/or different 
demands for good visual acuity between men and women depending on their 
respective everyday activities or differences in longevity, which could contribute 
to this difference.100, 103 However, the higher frequency of cataract surgery in 
women corresponds well with the higher prevalence of lens opacities in women, 
thus indicating that female gender truly increases the risk of cataract.100, 101 
The higher prevalence of cataract in women has led to extensive 
investigations about the effect of endogenous as well as exogenous estrogen in 
cataract formation. Data are conflicting, but the majority of studies in this area 
suggest a protective role for estrogen. Studies have shown that earlier menarche 
and/or later menopause, causing extended period of reproductive years, are 
associated with decreased risk of cataract, thus indicating that estrogens may 
have protective effects on the lens.104-107 Also, data from the Salisbury Eye 
Evaluation Project and the Beaver Dam Eye Study showed an association of 
increasing number of live births in younger women and protection against lens 
opacities.108, 109 However, other studies did not find support for such 
associations.110, 111 
Regarding exogenous estrogen, conflicting data exist both for the use of 
oral contraceptive pills and postmenopausal hormone replacement therapy 
(HRT). The Blue Mountains Eye Study showed a weak protective effect of oral 
contraceptive pills against the development of cortical cataract,110 but no such 
association could be found in other studies.104, 108 As for HRT, several studies 
indicate a protective effect of postmenopausal estrogen use against cataract.106-
108, 111 Other studies found no difference in overall cataract prevalence between 
HRT users and HRT non-users,110 and a few studies even demonstrate an 
increased incidence of cataract extraction among long-term users of HRT.112, 113 
Epidemiologic studies have shown that the gender difference in cataract 
prevalence occur in higher age-groups, after menopause, and that men, 
premenopausal women and women just entering menopause have the same 
prevalence of lens opacities and cataract extraction.16, 100 It has therefore been 
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hypothesized that the increased risk of cataract in women is due to the dramatic 
decrease in estrogen levels at menopause, i.e. a withdrawal effect of the 
potentially protective estrogen, in contrast to the more steady estrogen 
concentration in men. In addition, androgen deprivation in the treatment of 
prostate cancer has been linked to increased risk of cataract in a large 
epidemiological study, showing that hormonal status may be important in 
cataractogenesis in both genders.114 Also interesting, when comparing the serum 
concentration of 17β-estradiol (E2), the major estrogen in both genders before 
menopause, men have E2 levels in the same range as postmenopausal women 
(Table 1). There are even studies that have reported higher E2 levels in men 
compared to postmenopausal women.115, 116 
 
 
    
TABLE 1. Reference range for 17β-estradiol in men and women 
Women (menstrual cycle)                                                       17β-estradiol (pmol/L)                        
Follicular phase 77-921 
Periovulatory 139-2382 
Luteal phase 77-1145 
Postmenopausal <36-103 
Men <40-162 
The serum concentration of 17β-estradiol (E2) is shown for pre- and postmenopausal women and 
for men. Reference range from Sahlgrenska University Hospital, Gothenburg, Sweden, updated 
values from 2012. Concentrations account for total E2, both free and bound, in serum. 
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Estrogen 
The main source of circulating estrogen in premenopausal non-pregnant 
women is the ovaries. After menopause estrogen is formed in peripheral tissues 
and the mesenchymal cells of the adipose tissue overtake the role as the main 
source of estrogen. Cells in the testes produce estrogen but both intratesticular 
and extragonadal production, like adipose tissue, are of physiologic importance 
as sources of estrogen in men.117 Estrogens are steroid hormones that exist in 
three major naturally occurring forms. Estradiol (E2) is the predominant 
estrogen during the reproductive years in women compared to estrone (E1), 
which is the major estrogen after menopause and estriol (E3), which dominates 
during pregnancy when it is synthesized by the placenta. E2 possess 12 times 
higher estrogenic potency than E1 and 80 times higher than E3.118, 119 Their 
structures differ in the number of hydroxyl (OH) groups attached, as implied by 
their names (Figure 3). 
 
Figure 3. Chemical structures of estrogens; estrone (E1), estradiol (E2) and estriol (E3). 
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In the ovaries and testes estrogens are biosynthesized from cholesterol and 
testosterone respectively whereas in extragonadal sites estrogens are derived 
from C19 androgenic precursors.120 Cholesterol is converted into pregnenolone 
and then into progesterone and eventually into C19 androgenic precursors; 
dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), androstenediol 
and androstenedione, and the latter two can be converted into testosterone. The 
final step in the biosynthesis of E2 is through aromatization of testosterone or 
from E1 (Figure 4). E2 is bound to sex hormone-binding globulin (SHBG) or 
albumin and only a small fraction of E2 circulates unbound and free in the 
blood. E3 is formed both from E1 and E2 by conversion in the liver.118, 119 
Estrogen metabolism include both phase I enzymes and phase II enzymes. 
Cytochrome P450 (CYP) are phase I enzymes and CYP17A1 (17α-hydroxylase 
or 17,20 lyase) and CYP19A1 (aromatase) are some of the major isoforms of 
these enzymes, involved in the biosynthesis of estrogens.121 CYP1A1 is involved 
in the hydroxylation of E1 and E2 into their respective catechol estrogens, 
which results in lowered estrogenicity.122 The estrogen inactivation is then 
catalyzed by phase II enzymes, one of which is catechol-O-methyltransferase 
(COMT) that converts catechol estrogens through O-methylation into methoxy 
metabolites with low or no affinity for estrogen receptors (ERs).123, 124 
The biological effects of estrogens are many; both clinical and 
experimental studies show estrogens to be key regulators in tissue homeostasis 
by sensitizing cells to both mitogenic and apoptotic signals and by inducing 
expression of growth factors and cytokines.125 Estrogen is generally associated 
with a proliferative response and is mainly considered anti-apoptotic. However, 
under certain circumstances, estrogen may also initiate apoptosis, hence the 
expression ‘‘the estrogen paradox’’.126 Estrogens have been ascribed both 
antioxidative and pro-oxidative actions.127 Estrogens have been reported to 
induce mitochondria-dependent ROS generation, whereas other studies show 
an estrogen-dependent inhibition of ROS production.128, 129 The role of 
estrogens as ROS scavengers has therefore been argued. All estrogens are 
antioxidants since they contain a phenolic OH group at the C3 position in the A 
ring (Figure 3). The free radical scavenging effect of this phenol group is 
thought to mediate an ER-independent protection against neurodegeneration, 
and blocking of this ring leads to elimination of neuroprotection.130-132 
However, the phenolic OH group may act both as a proton donor and as an 
electron acceptor, thus exhibiting both pro- and anti-oxidative properties.  
 	   27 
 
Figure 4. Biosynthesis of estrogens; estrone (E1), estradiol (E2) and estriol (E3).  
CYP11A1: cytochrome P450 (CYP) 11A1 or P450scc (side-chain cleavage enzyme); CYP 17A1: cytochrome P450 (CYP) 
17A1 or 17α-hydroxylase/17,20 lyase; 3β-HSD: 3β-hydroxysteroid dehydrogenase; SULT2A: sulfotransferase; 17β-HSD: 
17β-hydroxysteroid dehydrogenase; CYP19A1: cytochrome P450 (CYP) 19A1 or aromatase.  
CYP11A1&
(P450scc)&
Estradiol*(E2)*
Testosterone(
Androstenedione(
Estrone*(E1)*
Progesterone( Pregnenolone(
Androstenediol(
Dehydroepiandrosterone(
(DHEA)(
17:OH:pregnenolone(17:OH:progesterone(
Cholesterol(
Dehydroepiandrosterone(sulfate(
(DHEAS)(
Estriol*(E3)*
CYP17A1&
(17α:hydroxylase)(&
CYP17A1&
(17,20&lyase)&
CYP19A1&
(aromatase)&
17β;HSD&&
17β;HSD&&
3β;HSD&&
17β;HSD&&
3β;HSD&&
3β;HSD&&
3β;HSD&&
16α;hydroxylase&
CYP17A1&
(17α:hydroxylase)(&
CYP17A1&
(17,20&lyase)&
SULT2A1&
CYP19A1&
(aromatase)&
16α;hydroxylase&
 	   28 
Estrogens can exert their actions by binding to their receptors ERα and ERβ. 
Several isoforms have been found of both the classical ERα and the more 
recently discovered ERβ. As for their affinity for different ligands, E2 binds 
equivalently to ERα and ERβ, whereas E1 prefers ERα and E3 binds 
preferentially to ERβ.133, 134 ERs located in the cytoplasm are kept in an inactive 
state by heat shock proteins (HSPs). Like other steroid hormones, estrogens can 
exert their actions through the classic genomic pathway by binding to ERs, 
which releases HSPs and exposes nucleus localization sequences, leading to 
translocation into the cell nucleus and binding to specific sites in DNA at the 
promoter site of target genes, called estrogen response element (ERE). This is 
followed by recruitment of co-regulators to the transcription start site leading to 
induced gene expression.135, 136 Apart from this classical signaling, another type 
of genomic mechanism of ER-signaling exists; transcription factor cross-talk, 
when ligand-activated ERs interact with with co-regulators and transcription 
factors, such as activator protein 1 (AP-1) and transcription factor Sp1, leading 
to induced gene expression.137, 138  
Non-genomic effects of steroids do not depend on gene transcription 
or protein synthesis and involve cytoplasmic or membrane-bound regulatory 
proteins or membrane-localized ERs. There are also ligand-independent 
pathways where ER activity can be regulated through activation of several 
different signal transduction pathways such as extracellular signal-regulated 
kinases (ERKs) included in the mitogen-activated protein kinase (MAPK) 
pathway.139 In addition, E2 have also been show to activate GPR30, belonging 
to the family of G-protein-coupled receptors, which is believed to be 
responsible for many of the rapid actions of estrogen.140 
 
 
Estrogen in cataractogenesis 
Both ERα and ERβ have been demonstrated in lenses from animals and 
humans.141-144As stated above, after menopause estrogens are no longer 
produced by the ovaries but are instead formed in peripheral tissues. In the rat 
retina, synthesis of E2 from pregnenolone and testosterone has been 
demonstrated, suggesting that some of the estrogen affecting the lens may come 
from intraocularly produced estrogen.145 Estradiol has been identified in the 
aqueous humor of humans, but the investigators did not find any differences 
between cataract patients and controls nor between men and women, when 
measuring E2 levels in aqueous humor and serum.146 
Since epidemiologic data shows increased risk of cataract in postmenopausal 
women, several groups have set out to investigate the effects of estrogen on the 
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lens in experimental models. Bigsby et al. showed in a rat model of age-related 
cataract that ovariectomized rats developed significantly less opacification of the 
lens if they received hormone replacement with E2 or E1.141 This was also 
supported by another study where lenses from ovariectomized rats were treated 
with E2 were protected from opacification by transforming growth factor β 
(TGFβ), indicating that E2 confers protection against induced cataract in female 
rats, since female rats were more resistant to TGFβ-induced cataract compared 
to males.147 Bigsby et al. also demonstrated that lens cells express both ERα and 
ERβ, thus implying that the protection by estrogen against cataract may be 
receptor-mediated.141 In addition, transgenic mice expressing a dominant 
negative form of ERα, inhibiting the receptor, spontaneously developed cortical 
cataract.148 
Given the antioxidative properties of estrogen described above, several 
investigators have examined the role of estrogens in human lens epithelial cells 
(HLECs) under conditions of oxidative stress. Estrogen-mediated protection 
from H2O2-induced oxidative stress in HLECs has been demonstrated in several 
studies.149-151 Gajjar et al. demonstrated that the protective effect of E2 was rapid 
and seen already within 5 minutes of pretreatment, indicating a non-genomic 
mode of action.150 Evidence for non-receptor mediated antioxidative protection 
also comes from Wang et al., who demonstrated a dose-dependent increase in 
cell viability and intracellular ATP levels by E2, effects that were not abolished 
by an estrogen receptor antagonist. Gottipati et al. have demonstrated a 
significant increase in SOD-2 activity levels in transformed lens epithelial cells 
(HLE-B3) after incubation with E2 without any changes in either mRNA or 
protein expression levels, suggesting non-genomic mechanisms of E2. 152 Flynn 
et al. demonstrated that E2 protected against H2O2-induced oxidative stress in 
HLECs from both male and female donors. However, silencing of ERβ resulted 
in collapse of mitochondrial membrane potential, indicating that although the 
estrogen-mediated protection against oxidative stress was gender-independent, 
it was ERβ-dependent.153 The exact mechanism, or relative contribution of 
genomic and non-genomic pathways in estrogen-mediated antioxidative 
protection remains to be elucidated. 
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Cataract & Heredity 
Genetic variation constitutes the basis for making individuals unique, but it also 
influence the susceptibility to genetic diseases. The most common form of 
genetic variation is called single nucleotide polymorphism (SNP), which is a 
change in a single base in our DNA. The variants of a SNP are called alleles and 
the two alleles carried by an individual together make up the genotype of that 
person. An individual with the same alleles on both chromosomes is 
homozygous and if the alleles are different, the individual is heterozygous for 
that specific SNP. Genetic association studies investigate if allele and genotype 
frequencies of SNPs occur in different frequencies in individuals with a certain 
disease compared to individuals who do not have the disease i.e. control 
subjects.154, 155 
Complex diseases or multifactorial diseases results from a combination 
of lifestyle related factors and a large number of common genetic variations, 
each contributing with only a minor increase in risk of disease. Unlike 
congenital cataract, which is largely inherited in a classical Mendelian manner 
involving single genes inherited in specific patterns, age-related cataract is a 
complex disease. Sibling correlations analyses from the Beaver Dam Eye Study 
suggested that a major gene could account for 58% and 35% of the genetic risk 
of developing cortical and nuclear cataract, respectively.26, 156 However, the 
relative contribution of genetic versus environmental effects were not measured 
in these studies. Twin studies performed by Hammond et al. have showed that 
environmental effects are in fact less important than previously believed and 
that genetic factors have the highest impact on risk of cataract, even more than 
aging itself. Heredity accounted for 58%, environment for 26% and age for 16% 
of the clinical variance for cortical cataract.157 For nuclear cataract the variance 
explained by genetic factors was 48%, environmental effects accounted for 14% 
and age for 38% of the variance.158  
A couple of candidate genes have been reported to be associated with 
age-related cataract such as GALK1, GSTM1 and EPHA2.159 The gene 
encoding ephrin receptor A2 (EPHA2) on chromosome 1 has been associated 
with both congenital and age-related cataract in several studies.160-163 
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AIMS 
 
The overall aim of this thesis was to study the role of estrogen and superoxide 
dismutase in cataractogenesis, including both cell culture and clinical studies. 
 
 
The specific aims of each paper were:  
 
Paper I 
• to study the effects of estrogen on proliferation, cell viability and 
intracellular redox status, as well as possible antioxidative properties of 
estrogens in human lens epithelial cells. 
 
 
Paper II  
• to investigate genetic variations of the three different superoxide 
dismutase genes in an association study including patients with cataract 
and controls. 
 
 
Paper III  
• to study genetic variations of several estrogen-related genes in an 
association study including patients with cataract and controls. 
 
 
Paper IV  
• to investigate the effect of estrogen on superoxide dismutase activity 
and expression as well as the effect on expression and subcellular 
distribution of estrogen receptors in human lens epithelial cells. 
 
 
Paper V  
• to measure serum levels of estradiol and superoxide dismutase activity 
in patients with cataract and in controls and to investigate a possible 
correlation between estradiol and superoxide dismutase. 
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MATERIAL & METHODS 
 
Cell culture 
 
Human lens epithelial cells 
Human lens capsule epithelium specimens were obtained during cataract 
surgery (phacoemulsification) at the Eye Clinic, Sahlgrenska University Hospital, 
in Mölndal, Sweden. The capsulorhexis specimens, usually 5 mm in diameter, 
were immediately after surgery put in tubes with cell culture medium. The lens 
epithelium specimens were then transferred from the tubes to 24-well culture 
dishes in a humidified 5% CO2 incubator at 37°C, after which the human lens 
epithelial cells (HLECs) started to proliferate. When confluent, the HLECs were 
subcultured by trypsin-EDTA treatment, followed by resuspension in cell 
culture media; Eagle’s minimum essential medium (MEM) or RPMI-1640 with 
phenol red supplemented with penicillin, streptomycin, L-glutamine, 
amphotericin B and 10% fetal bovine serum (FBS). 
Each cell line from one individual was subcultured and passages between 
IV and XV were used for experiments. Despite the HLECs being derived from 
cataractous lenses, morphology of the cells exhibited a normal epithelial pattern, 
with no gross deviations from normal lens epithelial cell appearance. 
 
Exposure to 17β-estradiol and oxidative stress 
Stock solution of E2; 17β-estradiol (10 mM) was prepared in 99.5% ethanol. In 
paper I, HLECs were incubated in triplicates with E2 (0.0001, 0.001, 0.01, 0.1, 1 
and 10 µM) in serum free cell culture media, RPMI-1640 without phenol red for 
24 h at 37°C in a humidified 5% CO2 incubator. For experiments where the 
antioxidative effect of E2 was studied, HLECs were preincubated with E2 for 
4h prior to addition of 25 µM H2O2 for 24h. In paper IV, prior to each 
experiment, cells were washed with Dulbecco’s phosphate buffered saline 
(PBS), after which the medium was changed to Eagle’s MEM without phenol 
red and 5% FBS for 22-24 h before exposure to E2 in serum free medium. 
HLECs were incubated in triplicates with E2  (0.1 µM and 1 µM) for 1.5 h or 24 
h. Control cells were incubated simultaneously, in an ethanol concentration 
equivalent to the highest E2 concentration, for 1.5 h or 24 h. 
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Cell viability & Cell death 
 
MTT assay 
MTT (3-[4, 5- dimethylthiazolyl-2]-2, 5-diphenyltetrazolium bromide) is cleaved 
by mitochondrial dehydrogenases to insoluble formazan crystals in metabolically 
active cells and this method was used to detect viable cells and to measure cell 
viability in paper I. MTT was added to HLECs cultured in a 96-well plate and 
the cells were then incubated for 4 h, after which formazan crystals were 
solubilized in DMSO.  Absorption was measured and the difference between 
the sample wavelength (570 nm) and the reference wavelength (650 nm) was 
calculated. 
 
Hoechst 
Hoechst 33342 is a specific stain for AT-rich regions of double-stranded DNA 
and used for the visualization of chromatin distribution in living cells. In paper I 
Hoechst was used to study the morphology of cell nuclei in HLECs in order to 
detect mitosis and apoptosis. Hoechst was also used to visualize nuclei for 
immunocytochemistry in paper IV. Cultured HLECs were fixed in 4% 
paraformaldehyde in PBS for 30 min, after which cells were stained with 
Hoechst for 15 min at 37°C. The coverslips were then mounted on chamber 
slides with Dako’s fluorescent mounting media followed by counting of stained 
cells in a fluorescence microscope. 
 
Caspase-3 
Caspases are proteases involved in apoptosis and caspase-3 is one of the 
executive caspases. In paper I, caspase-3 activity was measured to detect and 
quantify apoptosis. After exposure, HLECs were centrifuged at 350 g for 5 min. 
The medium was removed, and the well plates were immediately frozen at −152 
°C for at least 30 min. The frozen HLECs were thawed incubated in CHAPS-
containing buffer including protease inhibitors; trypsin inhibitor, pepstatin, 
leupeptin and PMSF for 30 min at room temperature. The synthetic fluorogenic 
substrate, Ac-DEVD-AMC (Ac-Asp-Glu-Val-Asp-AMC) and the reducing 
agent dithiothreitol (DTT) were added to the cell lysates. The fluorescent 
cleavage product of the substrate was measured during 2 h (Ex 380 nm, Em 460 
nm) and Vmax was determined in the linear interval. Proteolytic activity was 
expressed as the increase in relative fluorescence units per second and gram of 
protein (RFU s−1g−1).  
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Propidium iodide 
Propidium iodide (PI) is a stain that binds to double-stranded DNA and can 
enter and stain non-viable cells, but it cannot cross the membranes of viable 
cells. In paper I, PI was used to determine the percentage of non-viable cells. PI 
was used in cell culture media without phenol red, and added to the cells for 3 
min, after which fluorescence background was measured (Ex 540 nm, Em 620 
nm). In order to determine the total number of cells, CHAPS-containing buffer 
was added and the cells were frozen at −80 °C. After lysis of cells, HLECs were 
thawed and total cell lysate/density was measured. This method was also used 
as reference for relative cell density in other methods in paper I, i.e. peroxides, 
superoxides and glutathione levels. 
 
Intracellular redox status  
 
Peroxides 
The change in peroxide levels in paper I was measured using the non-
fluorescent, 2’,7’-dichlorofluorescein diacetate (DCFH-DA). In the cell, DCFH-
DA is cleaved by esterases yielding polarized DCFH trapped within the cells, 
which is then oxidized to fluorescent DCF by several ROS including different 
peroxides (but not superoxide and hydrogen peroxide). The amount of formed 
DCF may therefore be considered a measurement of peroxide levels in the cell. 
The cells were incubated with DCFH-DA for 30 min at 37 °C and peroxide 
levels  measured (Ex 490 nm, Em 535 nm). The method is often referred to 
as a general method of monitoring ROS generated in cells.  
 
Superoxides 
In paper I, superoxide levels were measured in HLECs using dihydroethidium 
(also called hydroethidine; HET), which is oxidized by superoxides to the 
fluorescent substance ethidium. Changes in ethidium concentration can hence 
be used as a measure of superoxide levels. The cells were preloaded with HET 
for 10 min at 37 °C, after which the cells were rinsed in PBS and cell culture 
media without phenol red was added. Changes in superoxide levels were 
measured after incubation in 37 °C for 30 min (Ex 510 nm, Em 600 nm). 
 
Glutathione 
The level of reduced glutathione (GSH) levels in HLECs was determined using 
monochlorobimane (MCB), in paper I. MCB forms a fluorescent conjugate 
together with GSH in a reaction catalyzed by glutathione S-transferase (GST). 
 were
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The final measurements were performed after 2 h (Ex 380 nm, Em 460 nm). 
Lower GSH levels indicate oxidation and the formation of oxidized glutathione 
(GSSG). 
 
Mitochondrial membrane potential – JC-1 
JC-1 (5,5′,6,6’-tetrachloro-1,1’,3,3′- tetraethylbenzimidazolylcarbocyanine iodide) 
was used in paper I to determine changes in mitochondrial membrane potential 
(∆ψ). HLECs were incubated with JC-1, after which the dye was removed, the 
cells were rinsed in PBS and serum free cell culture media was added. The green 
(Ex 485 nm, Em 535 nm) and red (Ex 540 nm, 590 nm) JC-1 signals were then 
measured. Oxidative stress usually causes a disruption of the mitochondrial 
membrane potential and the JC-1 dye indicates mitochondria depolarization by 
a decrease in the red to green fluorescence intensity ratio. In normal cells, due to 
the electrochemical potential gradient, the JC-1 dye is concentrated in the 
mitochondrial matrix, where it forms red fluorescent aggregates. A disruption of 
the mitochondrial membrane potential prevents the accumulation of the JC-1 
dye in the mitochondria and thus, the dye is dispersed throughout the entire cell 
leading to a shift from red (JC-1 aggregates) to green fluorescence (JC-1 
monomers). 
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Protein analyses 
 
Protein expression 
In paper IV, protein expression analyses were performed using western blot 
technique. HLECs were rinsed in ice cold PBS after exposure, followed by lysis 
in modified NuPage 0.5% lithium dodecyl sulfate (LDS) sample buffer. The cell 
lysate was heated at 70°C for 10 minutes and sonicated for 20 seconds at 50% 
amplitude. Immediately before gel loading, the reducing agent (DTT) was 
added. Triplets of the samples were loaded on NuPage 4-12% Bis-Tris gradient 
minigels using NuPage MES or MOPS SDS running buffer and sharp pre-
stained protein standard. After electrophoresis, the proteins were transferred to 
nitrocellulose membranes followed by a blocking in 5% non fat milk powder in 
PBS over night in +4 °C. Primary antibodies used for Western blotting 
included; polyclonal rabbit anti- ERα, ERβ and SOD-1 as well as monoclonal 
mouse anti- SOD-2 and β-actin. Primary antibody binding was detected with 
the corresponding secondary antibodies conjugated to horseradish peroxidase. 
Protein expression bands were visualized with Luminata Forte Western HRP 
Substrate in the ImageQuant LAS 500, followed by densitometric analysis using 
ImageJ software version 1.37. 
 
Protein determination  
Protein concentration of cell lysates was determined using the BCA protein 
assay reagent with BSA as the standard and absorption was measured at 570 
nm. This method was used in paper I, for caspase-3 assay and in paper IV for 
the SOD activity assay. 
 
Immunocytochemistry 
Immunocytochemistry was used in paper IV to visualize immunolabeling of 
ERα, ERβ, SOD-1 and SOD-2. After E2 exposure, the cells were rinsed in PBS 
and fixed in 4% paraformaldehyde (pH 7.4). The cells were rinsed again and 
permeabilized by 0.25% triton-X in PBS for 10 min at room temperature. 
Following standard protocols for immunocytochemistry, the cells were labeled 
with antibodies against ERα, ERβ,  SOD-1 and SOD-2 and visualized by Alexa 
Fluor 488 Goat Anti-Rabbit or Anti-Mouse IgG (H+L) antibodies. Nuclear 
morphology was viewed using Hoechst 33342. Prior to fixation, cells were 
incubated with MitoTracker Deep Red FM, which was used for mitochondrial 
localization. The cells were viewed using a fluorescence microscope. 
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Superoxide dismutase activity 
In paper IV, HLECs exposed to E2 were rinsed with PBS and the cell pellets 
were sonicated after which SOD activity was measured using the Superoxide 
Dismutase Assay kit, according to the manufacturer’s protocol (Cayman 
Chemical Company, Ann Arbor, MI, USA). Absorbance was measured at 440 
nm on the microplate reader Infinite M200 PRO (Tecan group Ltd., 
Männedorf, Switzerland). The SOD assay uses tetrazolium salt to detect 
superoxide radicals generated by xanthine oxidase and hypoxanthine. One unit 
(U) of SOD is defined as the amount of enzyme needed to exhibit 50% 
dismutation of the superoxide radical. The SOD assay measured total SOD 
activity (U/ml). In paper V, erythrocytes were collected from whole blood 
samples after centrifugation at 800 x g for 10 min at 4°C. The erythrocytes were 
then lyzed in four times its volume of ice-cold distilled water after which the 
samples were centrifuged at 10.000 x g for 15 min at 4°C. The erythrocyte lysate 
(supernatant) was then collected and aliquots were stored at -80°C, after which 
SOD activity was measured. 
 
Estradiol levels 
In paper V, venous blood samples were drawn from patients and controls and 
collected using tubes with clot activator and gel separator for serum samples. 
The serum sample tubes were centrifuged at 1800 x g for 10 minutes after 
coagulation, within 3 hours after sampling. Sera was then collected and aliquots 
were stored at -80°C. Serum E2 (17β-estradiol) analyses were performed with 
radioimmunoassay (Spectria Estradiol RIA, Orion Diagnostica, Espoo, Finland) 
with an extraction step prior to quantification, yielding a sensitivity of 4 
pmol/L. The assay measures total estradiol serum concentrations i.e. both free 
E2 and previously bound to sex hormone-binding globulin (SHBG) or albumin. 
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Molecular genetics 
 
SNPs & Haplotypes 
A combination of alleles from adjacent SNPs located on the same parental 
chromosome is called haplotype. Genetic recombination is a natural event 
during meiosis caused by pairing of parental chromosomes, which results in 
gametes of alternated segments of different parental origin. Adjacent SNPs are 
less likely to be recombined and will therefore be inherited together and will be 
correlated, which is referred to as SNPs being in linkage disequilibrium (LD). 
Groups of adjacent SNPs form LD blocks, also called haplotype blocks. Due to 
specific patterns in these blocks, specific SNPs can predict the other SNPs 
within the same block. These representative SNPs, called tag SNPs, can cover 
the entire variation of a gene or a region. Tag SNPs were used for haplotype 
analyses of SOD2 in paper II. 
All SNPs in paper II and III were checked for Hardy-Weinberg 
equilibrium (HWE), which is a measure of the correspondence between allele 
and genotype frequencies in a population where random mating without 
selection pressure occurs. Genotyping or data handling errors can be detected if 
analyses show deviation from HWE, i.e. significant difference between expected 
and observed allele frequencies (using χ2-test) in the disease and control group. 
Part of the reason for checking deviations from HWE is to test if a population 
is of homologous ethnic origin to avoid spurious association due to population 
stratification, but often lack of HWE is an indication of genotyping errors. 
 
Genotyping 
All the SNPs in paper II and III were genotyped using genomic DNA extracted 
from whole blood samples with TaqMan SNP Genotyping Assays. TaqMan 
Drug Metabolism Genotyping Assays were used for some of the SNPs in paper 
III. The TaqMan assays were used according to the TaqMan Allelic 
Discrimination technology. The technology uses fluorescent probes in 
polymerase chain reaction (PCR). Two probes are used, each sequence-specific 
for each allele and each are labeled with one fluorescent reporter dye each (VIC 
and FAM), together with a quencher that absorbs fluorescence at the other end 
of the probe. During the PCR when DNA polymerase extends the newly 
synthesized DNA strand, the probe is cleaved if it has bound (matched) the 
sequence specific for the allele and then the quencher will no longer be attached 
to the probe, resulting in increased fluorescence intensity from the specific 
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probe. If the probe does not bind (mismatch) the sequence in the allele, it will 
not be cleaved by the polymerase and there will not be an increase in 
fluorescence intensity. After the PCR amplification, the fluorescent signals are 
measured and plotted in an allelic discrimination plot, making it possible to 
discriminate between the genotypes. The signal from only one probe means that 
the individual is homozygous for the allele represented for that probe. If the 
individual is heterozygous, signals from both alleles will be detected (Figure 5).  
 
 
Figure 5. TaqMan Allelic Discrimination technology according to Livak et al. Fluorescent reporter 
dye (VIC and FAM) together with a quencher (Q), cleaved by DNA polymerase if the probe is a 
match (yielding fluorescence) and if mismatched the probe will be displaced (no fluorescene). The 
allelic discrimination plot displays genotypes for each individual; homozygous for allele 1 (blue), 
heterozygous (green) and homozygous for allele 2 (red). Non-template control (NTC) are also 
used to exclude any contaminations. 
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Gene expression 
In paper V TaqMan Gene Expression Assays were used specific for the studied  
(target) genes; SOD1, SOD2 and SOD3, and reference genes; RPLP0 and PPIA. 
Quantitative PCR (qPCR) was used to measure gene expression by quantifying 
the amount of mRNA, which first was converted to the more stable 
complementary DNA (cDNA) by reverse transcription PCR (RT-PCR), before 
it was used in the qPCR. The fluorescence from the sequence-specific TaqMan 
probes used in the qPCR, was measured in real-time. The fluorescence intensity 
for each sample is plotted against the amplification cycle and when calculating 
the relative quantification the cycle at threshold (Ct) is used. A threshold  is set 
in the exponential phase of the amplification curves and cycle at threshold is 
read for each sample (Figure 6). The Ct is inversely related to the amount of 
mRNA in the initial sample, i.e. the higher Ct value, the less amount of mRNA 
and lower gene expression. Data (Ct values) is then normalized to one or several 
reference genes to account for differences in starting material. Calculations of 
the relative gene expression are performed according to Livak and Schmittgen 
described here:  
Cttarget gene – Ctreference gene = ΔCt 
ΔCtexposed group – ΔCtunexposed group = ΔΔCt 
2
-ΔΔCt = fold change of relative expression 
 
 
Figure 6. Example of amplification plot where fluorescence intensity is plotted against 
amplification cycle. Threshold (green line) is set in the exponential phase of the amplification 
curves and cycle at threshold (black line) is read for each sample. 
threshold)
cycle)at)threshold)(Ct))
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Patients 
In paper II and III, Estonian patients with age-related cataract and controls 
were genotyped. The studied subjects consisted of 492 patients with age-related 
cataract and 185 controls, recruited from two ophthalmic clinics in Tartu and 
the South Estonian area. The cataracts were determined and classified into the 
following subtypes; cortical cataract (n=151), posterior subcapsular cataract 
(n=119), nuclear cataract (n=75) and mixed cataract (n=14 ). Classification was 
done prior to surgery, using biomicroscopy and ophthalmoscopy, and patients 
with secondary cataracts were excluded. Subjects without cataract, uveitis, and 
glaucoma were included as controls. Data on smoking (current and former 
smoking habits) was obtained for all individuals and age was reported at the 
time of surgery or when included in the study as controls. 
In paper V, patients were recruited at the Eye Clinic, Sahlgrenska 
University Hospital, in Mölndal, Sweden. The study subjects consisted of 103 
patients with age-related cataract and 22 controls. Cataracts were classified as 
nuclear, cortical, or posterior subcapsular using biomicroscopy and patients with 
secondary cataracts were excluded. Controls were either spouses or relatives to 
glaucoma patients, had glaucoma themselves or were recruited from the 
emergency ophthalmic clinic, with diagnoses such as vitreous detachment or 
blepharitis. Exclusion criteria for controls were previous cataract surgery or lens 
opacities and age <60 years. Data on smoking (current/former smoking habits), 
hormones (current/former use of contraceptives and/or hormone replacement 
therapy), diabetes and age at menarche/menopause was obtained for all 
individuals and age was reported at the time of sample collection. 
 
Ethics  
In all the studies included in this thesis, written informed consent was obtained 
and the studies were conducted following the tenets of the Declaration of 
Helsinki. The Regional Research Ethics Committee in Gothenburg approved 
the studies in paper I, IV and V. The Ethical Commission at the University of 
Tartu in Estonia approved the studies in paper II and III. 
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Statistics 
In the cell culture studies, paper I and IV, one-way ANOVA with Dunnett’s 
post hoc test were used to compare exposed groups with unexposed control 
group. The gene expression data, in paper IV, was normalized to the reference 
genes, RPLP0 and PPIA, and compared to the expression in control cells 
according to the 2-ΔΔCt method, using a linear mixed model. 
In paper II, III and V, demographic differences between cataract patients 
and control subjects were analyzed using Student's t-test for continuous 
parameters and Pearson's chi-square test (or Fisher’s exact test when 
appropriate) for categorical parameters. Also one-way ANOVA was used when 
comparing age between the different subtypes of cataract. In paper II and III, 
single marker association tests were performed using logistic regression in an 
additive model (homozygote for major allele=0, heterozygote=1 and 
homozygote for minor allele=2), including relevant risk factors for age-related 
cataract; age, sex and smoking, as covariates in the analyses. Binary logistic 
regression was also used when performing single marker associations between 
the different subtypes. Differences between allele frequencies were analyzed 
with chi-square test. All SNPs were analyzed for deviation from Hardy-
Weinberg equilibrium and haplotype analysis (paper II) was performed using 
Haploview 4.2. Bonferroni correction was used to adjust for multiple testing in 
paper III. In paper V, multiple linear regressions were used to analyze potential 
predictors of the dependent variables; E2 levels and SOD activity.  
Statistical analyses were performed using IBM SPSS Statistics versions 
18-21 (IBM Corp., Armonk, NY, USA) and p-values ≤0.05 were considered 
statistically significant.  
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RESULTS & DISCUSSION 
 
Effects of estrogen in HLECs (paper I and IV) 
Since estrogens have been ascribed both antioxidative and pro-oxidative actions 
and the effects of different doses differ between cell lines, dose-response 
experiments were performed initially. The effects of 17β-estradiol (E2) were 
then studied at concentrations between 0.1 nM and 10 µM (paper I), which are 
relevant physiologic and pharmacological concentrations. Two concentrations, 
0.1 µM and 1 µM, were chosen for further studies (paper IV).  
 
Oxidative effects of estrogen 
In paper I, HLECs exposed to 10 µM E2 resulted in a significantly lower 
number of viable cells, decreased number of mitotic nuclei, an increase in the 
relative number of non-viable cells i.e. increased cell death, as well as increase in 
the number of apoptotic nuclei and  caspase-3 activity. Both an increase 
in peroxide and superoxide levels was observed. There was also a decrease in 
GSH levels at the same concentration of estrogen. Results from paper I 
therefore suggest pro-oxidative effects of the pharmacological (10 µM) E2 
concentration (Table 2). However, mitochondrial membrane potential was not 
affected, indicating that this increased ROS production did not interfere with 
mitochondrial function. 
	  	   	  	  
Table 2. Effects of E2 at the pharmacological concentration, 10 µM 
Cell viability (MTT)  "  
Mitosis (Hoechst) " 
Cell death (PI) # 
Apoptosis (Caspase-3) # 
Apoptosis (Hoechst) # 
ROS (Peroxides) # 
ROS (Superoxides) # 
Reduced glutathione (GSH) " 
The effects of 17β-estradiol (E2) were compared to control cells (0 µM E2). 
 
 increased
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The exact mechanism for estrogen-mediated apoptosis is not clear; both 
extrinsic and intrinsic apoptotic pathways exist, the latter being triggered by 
collapse of mitochondrial membrane potential. Our data demonstrate caspase-
dependent apoptosis at pharmacological concentration of E2, without 
mitochondrial depolarization. 
 
Proliferative effects of estrogen 
In paper I, lower concentrations of E2 (1 nM), showed an increase in the 
number of mitotic nuclei and decrease in cell death, which was observed with 
Hoechst and PI, respectively. Results from paper I suggest proliferative effects 
of E2 at lower concentration, 1  and the stimulatory effect of physiologic 
concentrations of estrogen on proliferation of cultured HLECs in this study is 
especially interesting from an ophthalmologic view since female gender has 
been suggested as a risk factor for developing posterior capsular opacification 
(PCO).164 Data from our group also show a slightly higher rate of cell growth in 
capsule-epithelium specimens derived from female cataract patients compared 
to men.165 
 
Estrogen protection against oxidative stress 
To examine the effect of E2 in oxidatively stressed HLECs in paper I, the cells 
were preincubated with E2 at different concentrations for 4 h and then 
simultaneously exposed to 25 µM H2O2 and E2 for 24 h. At lower 
concentrations, 0.01 to 1 µM, E2 protected against oxidative stress, as evident 
by decreased peroxide and superoxide levels as compared to control cells 
exposed to H2O2 alone (Figure 7). The peroxide levels in HLECs incubated with 
E2 were reduced to the same level as in control cells not exposed to H2O2. 
Superoxide levels were also decreased but not to the same extent as in cells 
without H2O2 exposure. An increase in the mitochondrial membrane potential 
(JC-1) was seen in the lower range of E2 concentrations used, 0.1–10 nM. 
However, E2 did not reverse the effects of 25 µM H2O2 on mitochondrial 
membrane potential or GSH levels. Other studies have also demonstrated 
estrogen-mediated protection against H2O2-induced oxidative stress in a 
transformed human lens epithelial cell line (HLE-B3). Pretreatment with E2 
caused a dose-dependent preservation of mitochondrial potential, intracellular 
ATP-levels and increased cell viability. However, no effects on ROS levels were 
seen in the same study at concentrations ranging from 1 nM to 10 µM E2, when 
using 100 µM H2O2 to oxidatively stress lens epithelial cells.166 This is thus in 
contrast to our data from paper I where E2 reversed the increase in peroxide 
nM
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and superoxide levels seen in HLECs exposed to 25 µM H2O2. The H2O2-
concentration, 25 µM, used in experiments in paper I was well within the 
reported range of H2O2 found in aqueous humor of cataract patients,35 and was 
chosen since this level of H2O2 induced ROS-production but did not cause 
apoptosis. Even though we did not detect estrogen-mediated protection of 
mitochondrial membrane potential against H2O2-induced oxidative stress, the 
results from paper I still indicate protection against oxidative stress, suggesting 
antioxidative effects of E2 at lower (0.01 to 1 µM), more physiologic 
concentrations. 
 
Figure 7. Antioxidative effects of 17"-estradiol (E2) against oxidative stress. Human lens 
epithelial cells preincubated with E2 for 4 hours after which cells were simultaneously exposed to 
25"M hydrogen peroxide (H2O2) for 24 h. A significant decrease in peroxide (left) and superoxide 
(right) levels compared to control cells exposed to H2O2 but not E2. Peroxide levels reduced to 
same levels as unexposed cells. Asterisks indicate statistical significance p<0.05. 
 
 
Effects of estrogen on SOD expression and activity 
In paper IV, strong immunolabeling with SOD-1 was seen in the cytosol and 
nucleus in contrast to SOD-2 where mitochondrial localization dominated for 
SOD-2. No subcellular redistribution of SOD-1 or SOD-2 was seen with E2 
exposure. SOD-1 is the predominant isoenzyme in the lens and the amount of 
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SOD-2, which is likely confined to the lens epithelium, is relatively low in the 
human eye lens and the content of SOD-3 is negligible.85 Therefore it is not 
surprising that we observed lower gene expression levels of SOD3 in HLECs as 
compared to SOD1 and SOD2 levels. However, we found no significant 
changes in SOD1, SOD2 or SOD3 gene expression neither after 1.5 h nor after 
24 h exposure to 0.1 µM and 1 µM E2, when compared to the expression in 
control cells and after normalization to reference genes. A slight increase in 
both SOD-1 and SOD-2 protein expression was seen at 0.1 µM after 1.5 h and 
elevated SOD-2 levels were also seen at 1 µM E2 after 24 h. However, these 
results were not statistically significant compared to control cells. A significant 
increase in total SOD activity was seen in whole cell lysate from HLECs after 
exposure to 0.1 µM and 1 µM E2 for 1.5 h. By 24 hours however, SOD activity 
was back to baseline values. Thus, the effects of E2 on SOD activity did not 
correlate with protein or gene expression of the different SODs. The results 
from paper IV are in accordance with Gottipati et al. who showed a significant 
increase in SOD-2 activity levels in HLE-B3 cells after exposure to E2 without 
any changes in either mRNA or protein expression levels.152 A few other studies 
have also reported increased SOD-2 activity levels without alteration of SOD-2 
protein levels in mitochondria after E2 exposure.167, 168 However, yet other 
studies report both upregulated gene and protein expression of SOD-2 and 
SOD-3 in an E2 concentration- and time-dependent manner mediated by ERs, 
in vascular smooth muscle endothelial cells.169 Also, E2 showed antioxidative 
effects by upregulation of GPx and SOD-2 expression via activation of the 
MAPK pathway through ERK phosphorylation.170 The discrepancies regarding 
E2 effects on SOD in both protein and gene expression may be attributed to 
differences between cell lines. The exact mechanism, or relative contribution of 
genomic and non-genomic pathways in estrogen-mediated antioxidative 
protection remains to be elucidated. Results from paper IV demonstrate that E2 
have effects on SOD activity but not on gene or protein expression of SODs, 
thus implying non-genomic mechanisms of E2.  
Protein expression and immunolocalization of estrogen receptors 
In paper IV, we showed that both ERα and ERβ were present in the nucleus 
and mitochondrial localization of ERβ was evident by colocalization with 
MitoTracker. Our results also showed reduced ERα expression levels as well as 
the reversed effect, elevated ERβ expression levels and increased 
immunolabeling, with increased E2 concentration. This may be explained by a 
study showing that ERβ exhibits an inhibitory effect on ERα-mediated gene 
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expression, when ERs are coexpressed.134 The mitochondrial localization and 
elevated expression levels of ERβ due to E2 exposure indicate mitochondrial 
involvement, and this supports that the suggested E2-induced mitochondrial 
cytoprotective effects are mediated through ER-dependent mechanisms in 
HLECs. 
 
Native human lens epithelial cells vs. transformed lens epithelial cell line 
Results are preferably compared to experiments using the same cells as in your 
own experiments, but this may be difficult since few studies use the exact same 
cells. In paper I and IV, native HLECs were used in contrast to most studies 
performed so far on estrogen and ERs in lens epithelial cells, in which the 
transformed human lens epithelial cell line, HLE-B3, was used. The relative 
abundance and preferential subcellular distribution of the two ERs and their 
respective isoforms exhibit substantial variations between species as well as 
between freshly isolated capsulorhexis specimens and cultured HLECs and also 
in native versus transformed cells.171, 172 The intracellular localization and ratio 
between ERα and ERβ have been suggested to account for much of the 
differences seen in estrogen response in various cell types and may also explain 
discrepancies between studies performed on native HLECs and HLE-B3. Flynn 
et al. have demonstrated a difference in ERβ variants distribution and RNA 
expression as well as responsiveness to oxidative stress between HLECs and 
HLE-B3.173 However the subcellular localization of wild-type ERβ were the 
same for the different cell lines and in accordance with our results.  
Whenever possible, using native cells - as in paper I and IV - is 
preferable. The use of immortalized and transformed cell lines such as HLE-B3 
has been questioned since the cells are adapted and likely to lose characteristics 
that are critical to their function in vivo.174 
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Genetic variations in superoxide dismutase and estrogen-
related genes in cataract (paper II and III) 
 
Superoxide dismutase genes 
In paper II, polymorphisms in the three SOD genes (SOD1, SOD2 and SOD3) 
were studied in Estonian patients with age-related cataract and controls. The 
eight studied SNPs were either functional, disease-associated or tag SNPs. 
However, none of the studied SNPs showed significant associations with risk of 
cataract, neither in univariate analyses nor when having the known risk factors; 
age, sex and smoking as covariates in multivariate analyses. These results were 
consistent also after stratifying for type of cataract. Paper II, thus does not 
support a major role for SOD gene variations in cataractogenesis. 
 
Estrogen-related genes 
In paper III, eight either functional or disease-associated SNPs in estrogen-
related genes were studied in the same Estonian population as in paper II. The 
estrogen-related genes encoded ERs (ESR1, ESR2) and enzymes involved in 
the biosynthesis (CYP17A1, CYP19A1), bioavailability (CYP1A1) and 
inactivation (COMT) of estrogens. None of the SNPs showed significant 
associations with risk of cataract when comparing all cases and controls, neither 
in the univariate analyses nor when adding the known risk factors (age, sex and 
smoking) as covariates in the analyses. After stratification by cataract subtype, 
the nuclear cataract group had a significantly lower minor (C) allele frequency of 
rs10046 (CYP19A1) compared to the control group (p=0.026). After including 
covariates in the analysis the adjusted odds ratio (OR) was 0.56 with a 95% 
confidence interval of 0.35 to 0.90, p=0.016. However, after correcting with 
Bonferroni for multiple testing of the eight SNPs in the four different cataract 
subtypes, this finding was no longer significant (p=0.51). Thus, paper III does 
not support a major role for genetic variations in estrogen-related genes to be 
involved in cataractogenesis. 
 
Estonian patients and controls 
There was no difference in gender distribution between patients and controls in 
the Estonian study population. The higher frequency of nuclear opacities 
among smokers in the Estonian cohort is also in accordance with epidemiologic 
data reporting smoking as a risk factor for nuclear cataract.14, 21, 22 
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A limitation of both paper II and III was the number of study 
participants, especially controls, included in the Estonian study population 
which may have contributed to the inconclusive results. Other limitations were 
that the mean age was significantly lower in the control group, resulting in a 
number of "false negative" control subjects who may develop cataract in the 
next few years. In addition, there was no information about the composition of 
mixed cataracts, which - if available - would have enabled sorting of mixed 
cataracts into defined subtypes. 
 
Estrogen levels and superoxide dismutase activity in 
cataract patients and controls (paper V) 
To date, no other study has investigated both serum estradiol levels and 
erythrocyte superoxide dismutase activity in patients with cataract. This makes 
the investigation in paper V, unique. Comparisons between the cataract group 
and control group have been performed in this study even though a weakness 
was the number of controls, only 22 subjects were included compared to 103 
cataract patients. As in the Estonian study population in paper II and III, there 
was no difference in gender distribution between patients and controls. In this 
study we could however divide the patient by type of lens opacities so that a 
patient with mixed cataract could be included in several subtypes, and this is 
considered an advantage. However, the diabetic incidence was higher among the 
patients while none of the controls had diabetes something that may be 
explained by the increased risk of developing lens opacities when having 
diabetes.25 
 
Estradiol levels in serum 
In our studied subjects, in paper V, men had significantly higher E2 levels 
compared to postmenopausal women (p<0.001). It has previously been 
reported that serum E2 levels are higher in older men than in older women due 
to higher levels of testosterone and DHEA in men, resulting in higher E2 
through peripheral aromatization, thus yielding higher E2 levels in men 
compared to women after menopause.115, 116 This means that the potentially 
protective effects of E2 that are dramatically reduced at menopause are even 
below men’s levels, therefore possibly contributing to increased risk of cataract. 
This would also contribute to the reduced risk of cataract in women using HRT, 
as implied by several studies.106, 107, 111As expected a linear relation between 
increasing age and declining E2 levels i.e. a negative correlation was observed. 
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Multivariate analysis showed significant impact of both age (p=0.021) and sex 
(p=<0.001) on E2 levels, but cataract diagnosis on the other hand did not. 
 
Superoxide dismutase activity in erythrocytes 
No correlation was seen with SOD activity and age, gender or cataract diagnosis 
in paper V. There have been reports of increased SOD activity in erythrocytes 
in cataract patients compared to controls as well as an increased incidence of 
cortical cataract in patients with high SOD activity in erythrocytes.92-94 Rajkumar 
et al. demonstrated increased SOD activity in lens capsules samples from cortical 
cataract patients and the activity declined gradually with age in all samples; the 
highest levels of SOD were found in samples from patients 50 years of age or 
younger.91 However, conflicting data on SOD activity levels also exist and there 
are studies showing decreased SOD activity levels in erythrocytes, sera and 
lenses from cataract patients compared to controls.95-97 Our data could not 
confirm any correlations with SOD activity in erythrocytes.  
 
Estradiol vs. Superoxide dismutase 
No correlation between SOD activity and E2 levels was found, not even when 
including age, gender and diagnosis in the model. Even though in vitro studies 
have demonstrated that E2 can influence SOD expression and/or activity, we 
could not find any correlation between SOD activity and E2 concentration in 
our studied subjects. 
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CONCLUSIONS 
 
Effects of estrogen in human lens epithelial cells were  
 
• increased proliferation, reduced cell death, stabilization of 
mitochondrial membrane potential  and protection against oxidative 
stress at  lower (physiologic) concentrations. 
 
• increased caspase-3 activity, apoptosis, cell death and intracellular 
reactive oxygen species as well as reduced GSH levels, cell viability and 
proliferation at higher (pharmacological) concentrations. 
 
 
Genetic variation in superoxide dismutase and estrogen-related genes 
was 
 
• not associated with increased risk of cataract in an Estonian population. 
 
 
Effects of estrogen on superoxide dismutase and estrogen receptors in 
human lens epithelial cells were 
 
• increased total superoxide dismutase activity. 
 
• unchanged protein and gene expression of superoxide dismutases. 
 
• altered protein expression levels of estrogen receptors. 
 
 
Estrogen levels and superoxide dismutase activity in cataract patients 
and controls showed 
 
• a linear correlation between increasing age and declining estradiol 
levels. 
 
• higher estradiol levels in men compared to postmenopausal women. 
 
• no correlation between superoxide dismutase activity and estradiol 
levels in our studied subjects. 
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Concluding remarks 
Cataract is the most common cause of blindness in the world and the only 
treatment for cataract today is to surgically remove the lens, most often 
replacing it with a plastic lens prosthesis. In the western world, cataract 
extraction is the most frequent surgical procedure and as lifespan is getting 
longer, an increased number of people requiring cataract surgery can be 
anticipated. Cataract surgery is not without risks and postoperative 
complications, together with high healthcare costs for society as well as visual 
impairment and disability affecting people's everyday life, are reasons to 
continue investigating the underlying mechanisms and to find preventive actions 
against cataract formation. The idea has been launched of a chemical, rather 
than the present surgical solution to the cataract disease.175 Even if a non-
surgical treatment of cataract cannot be invented, the possibility of delaying the 
onset of the disease would also have a great impact on the prevalence of the 
disease. Studies have shown that if one succeeds to find ways to delay cataract 
formation with 10 years, the number of required cataract surgeries would be 
reduced by 45%.176 
Many lifestyle-related factors are exogenous sources of oxidative stress 
associated with cataractogenesis. Therefore many suggested preventative actions 
involve these factors, such as UVB exposure and smoking. Wearing a hat and 
UVB-protecting sunglasses and avoiding direct sunlight at peak hours of UVB 
radiation have been suggested as powerful preventative measures. Studies have 
shown dose-response associations between smoking and risk of cataract among 
current and former smokers and it has been demonstrated that the risk of 
developing cataract decreases with time in former smokers, thus promoting 
smoking cessation. The association between cataract and smoking was also 
confirmed in the present thesis. Dietary antioxidants have been suggested to 
reduce the risk of cataract but the results have been inconsistent. It has also 
been suggested that the possible protective effect of antioxidant supplements in 
the middle age is not sufficient to reduce oxidative damage that has already been 
caused and therefore lifelong vitamin supplementation would be required.177 
Whether or not the lifestyle changes described above are feasible in order to 
avoid cataract surgery, must be decided by each individual. 
The most common postoperative complication after cataract surgery, 
posterior capsular opacification (PCO), is caused by proliferation of residual 
lens epithelial cells on the lens capsule. Our results indicate proliferative effects 
by low levels of E2 exposure, which would have negative effects in this context. 
The biological effects of estrogens are many and are even associated with 
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increased risk of developing certain hormone-sensitive cancers. Even if our 
results showed estrogen-mediated protection against oxidative stress, they do 
not encourage intake of estrogens. As mentioned, estrogen exerts different 
effects in different cell lines and estrogen-mediated protection is both 
concentration- and time-dependent. The mechanism for possible estrogen-
mediated protection against cataract formation is still not clear. The main 
finding of this thesis is that estrogen exerts both pro- and anti-oxidative effects 
on the lens. Estrogen-mediated protection has been implied in several other 
age-related diseases as well. Therefore, studies on lens epithelial are important 
since the lens may serve as a useful model for studying estrogen-mediated 
protective and/or harmful effects in other age-related diseases and in biological 
aging in general.  
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SUMMARY IN SWEDISH / SVENSK SAMMANFATTNING 
 
Katarakt (grå starr) är en synstörande grumling av ögats lins och den största 
riskfaktorn för katarakt är åldrande. En av de viktigaste bidragande faktorerna 
till sjukdomen är oxidativ stress och epidemiologiska studier har visat att 
kvinnor har högre risk än män att få katarakt. Den här könsskillnaden i 
kataraktrisk uppstår först i högre åldrar, d.v.s. efter klimakteriet hos kvinnor och 
i motsvarande ålder hos män. Man tror att östrogen kan ha en skyddande effekt 
mot katarakt och att de minskade östrogen-nivåerna efter klimakteriet kan vara 
orsaken till denna könsskillnad. Orsaken till att östrogen tros skydda mot 
katarakt är inte känd men experimentella studier har visat att östrogen kan verka 
antioxidativt, dvs. skydda mot fria radikaler (oxidativ stress). Syftet med den här 
avhandlingen var att undersöka mekanismen bakom ett eventuellt östrogen-
medierat skydd mot katarakt samt att studera hur östrogen påverkar ett av de 
viktigaste antioxidativa systemen i cellen, superoxiddismutas. 
Humana linsepitelceller, vilka erhållits vid kataraktkirurgi odlades och 
exponerades sedan för olika koncentrationer av 17β-östradiol (den vanligaste 
formen av östrogen) varefter effekten av detta hormon studerades. Cellerna 
utsattes också för oxidativ stress genom exponering för väteperoxid, med och 
utan östrogen, för att studera detta hormons eventuella antioxidativa effekter. I 
kliniska studier undersöktes serum-koncentrationerna av östrogen och 
aktiviteten hos superoxiddismutas hos kataraktpatienter respektive hos 
kontrollpersoner av båda könen. Dessutom studerades genetiska variationer 
(polymorfismer) i östrogen-relaterade gener samt i generna för 
superoxiddismutas, hos kataraktpatienter och kontrollpersoner.  
Sammanfattningsvis visade våra studier att östrogen ökade aktiviteten 
av superoxiddismutas och minskade de fria radikalerna i humana linsepitelceller. 
Detta visar att östrogen kan verka antioxidativt och kan skydda mot oxidativ 
stress i humana linsepitelceller. De kliniska studierna gav dock inget stöd för att 
genetiska variationer i östrogen-relaterade eller i superoxiddismutas-gener skulle 
öka risken att få katarakt. Det fanns inte heller något samband mellan serum-
koncentrationerna av östrogen och aktiviteten hos superoxiddismutas hos 
kataraktpatienter och kontrollpersonerna. Katarakt är idag den vanligaste 
orsaken till blindhet globalt sett och kataraktextraktion är det vanligaste 
kirurgiska ingreppet i västvärlden, inklusive Sverige. Detta innebär stora 
samhällsekonomiska kostnader och orsakar funktionshinder hos patienter med 
nedsatt syn tiden före operation. Det är därför viktigt att fortsätta sökandet efter 
de underliggande orsakerna till katarakt och försöka hitta förebyggande åtgärder 
mot utvecklingen av katarakt. Katarakt uppvisar också likheter med andra 
vanliga åldersrelaterade sjukdomar och kan därför användas som en modell i 
studier av biologiskt åldrande. 
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